We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.45B
AUM Growth
+$379M
Cap. Flow
+$62.7M
Cap. Flow %
1.15%
Top 10 Hldgs %
26.99%
Holding
161
New
18
Increased
65
Reduced
42
Closed
14

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$43.7M
2
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$39.4M
3
LAD icon
Lithia Motors
LAD
+$30.5M
4
PANW icon
Palo Alto Networks
PANW
+$25.7M
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$25.5M

Top Sells

Rank Stock Value
1
GTM
ZoomInfo Technologies
GTM
+$82.3M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$41.8M
3
IMVT icon
Immunovant
IMVT
+$40M
4
DV icon
DoubleVerify
DV
+$35.4M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$34.4M

Sector Composition

Rank Sector Weight
1 Healthcare 43.08%
2 Technology 23.47%
3 Industrials 13.06%
4 Consumer Discretionary 7.01%
5 Utilities 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNS
76
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$21.9M 0.4%
3,173,197
+23,197
+0.7% +$145K
IMVT icon
77
Immunovant
IMVT
$7.89B
$21.6M 0.4%
1,390,000
-2,303,720
-62% -$40M
BILL icon
78
BILL Holdings
BILL
$4.5B
$21.5M 0.39%
264,398
-912
-0.3% -$84.6K
PRTA icon
79
Prothena Corp
PRTA
$425M
$21.3M 0.39%
438,732
– –
NDAQ icon
80
Nasdaq
NDAQ
$52.8B
$21.2M 0.39%
388,601
-82,982
-18% -$4.8M
WMB icon
81
Williams Companies
WMB
$87.7B
$21M 0.39%
704,707
-58,232
-8% -$1.8M
KLAC icon
82
KLA
KLAC
$244B
$20.4M 0.37%
511,590
+5,970
+1% +$235K
NOVT icon
83
Novanta
NOVT
$5.13B
$20M 0.37%
125,954
+54
+0% +$8.29K
RGEN icon
84
Repligen
RGEN
$8.04B
$20M 0.37%
119,000
– –
BPMC
85
DELISTED
Blueprint Medicines
BPMC
$19.7M 0.36%
438,500
– –
CYTK icon
86
Cytokinetics
CYTK
$10.6B
$19.6M 0.36%
556,000
– –
MASS icon
87
908 Devices
MASS
$324M
$19.2M 0.35%
2,230,665
– –
ISRG icon
88
Intuitive Surgical
ISRG
$127B
$19.2M 0.35%
75,029
+29
+0% +$7.14K
NTLA icon
89
Intellia Therapeutics
NTLA
$1.5B
$18.4M 0.34%
493,222
+174,222
+55% +$6.83M
KYNB
90
Kyntra Bio
KYNB
$27.6M
$17.9M 0.33%
+38,400
New +$20.3M
BRKR icon
91
Bruker
BRKR
$9.6B
$17.4M 0.32%
220,803
+18,797
+9% +$1.36M
ELS icon
92
Equity Lifestyle Properties
ELS
$12.6B
$16.6M 0.3%
246,737
+123,352
+100% +$8.37M
VCYT icon
93
Veracyte
VCYT
$3.73B
$16.3M 0.3%
732,000
– –
BMRN icon
94
BioMarin Pharmaceuticals
BMRN
$11.6B
$16M 0.29%
164,299
-65,701
-29% -$6.81M
BLU
95
DELISTED
BELLUS Health Inc.
BLU
$15.9M 0.29%
+2,210,000
New +$17.1M
BBIO icon
96
BridgeBio Pharma
BBIO
$15.7B
$15.6M 0.29%
+941,176
New +$11M
INSM icon
97
Insmed
INSM
$21.2B
$15.6M 0.29%
912,103
+213,690
+31% +$4.15M
RCKT icon
98
Rocket Pharmaceuticals
RCKT
$341M
$15.4M 0.28%
898,000
+427,346
+91% +$8.37M
PNR icon
99
Pentair
PNR
$10.4B
$15M 0.28%
271,505
-78,895
-23% -$4.19M
SYY icon
100
Sysco
SYY
$40.9B
$14.8M 0.27%
191,333
+14,233
+8% +$1.09M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Eventide Asset Management held 161 positions worth $5.45B, up 7.5% from $5.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management's Q1 2023 filing shows 18 new, 65 increased, 42 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 125,499 shares worth $28.7M. The largest sale was ZoomInfo Technologies, an estimated $82.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2023 buy was Lithia Motors: 125,499 shares worth $28.7M.
  • Eventide Asset Management added most to Doximity in Q1 2023, an estimated $43.7M increase.
  • Eventide Asset Management's biggest Q1 2023 reduction was ZoomInfo Technologies, cutting an estimated $82.3M.
  • Eventide Asset Management fully exited Bicycle Therapeutics in Q1 2023, selling an estimated $25.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $5.45B portfolio in Q1 2023.
  • Eventide Asset Management opened 18 new positions and closed 14 in Q1 2023.
  • Eventide Asset Management's portfolio value rose 7.5% quarter-over-quarter to $5.45B.

Based on Eventide Asset Management's 13F filing for Q1 2023, filed 15 May 2023.